Dihydropyridine Calcium Antagonists Increase Fibrinolytic Activity: A Systematic Review

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Cerebral Blood Flow and Metabolism

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.jcbfm.9600431PMID 17191079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Calcium Antagonists for Aneurysmal Subarachnoid Hemorrhage

  2008cited by this paper
• Hyperglycemia Stimulates Coagulation, Whereas Hyperinsulinemia Impairs Fibrinolysis in Healthy Humans

  2006cited by this paper
• Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled tri

  2005cited by this paper
• Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

  2005cited by this paper
• Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.

  2005cited by this paper
• Inhibition of plasminogen activator inhibitor-1 by angiotensin II receptor blockers on cyclosporine-treated renal allograft recipients.

  2005influential reference
• Calcium antagonists for aneurysmal subarachnoid haemorrhage.

  2005cited by this paper
• Platelets synthesize large amounts of active plasminogen activator inhibitor 1.

  2004cited by this paper
• Regulation of local availability of active tissue‐type plasminogen activator in vivo in man

  2004cited by this paper
• Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise

  2004influential reference
• Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects.

  2004cited by this paper
• Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.

  2004influential reference
• Association between obesity and a prothrombotic state: the Framingham Offspring Study

  2004cited by this paper
• Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.

  2004influential reference
• Effect on Cerebral Vasospasm of Coil Embolization Followed by Microcatheter Intrathecal Urokinase Infusion Into the Cisterna Magna: A Prospective Randomized Study

  2003cited by this paper
• Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients

  2003influential reference
• Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension.

  2003cited by this paper
• Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• [Coagulative and fibrinolytic changes in patients with essential hypertension and the effect of sustained-release nifedipine].

  2002influential reference
• Detection of Microemboli by Transcranial Doppler Ultrasonography in Aneurysmal Subarachnoid Hemorrhage

  2002cited by this paper
• Fosinopril Versus Amlodipine Comparative Treatments Study: A Randomized Trial to Assess Effects on Plasminogen Activator Inhibitor-1

  2002influential reference
• Haemorheological and endothelial‐dependent alterations in heart failure after ACE inhibitor, calcium antagonist and β blocker

  2002influential reference
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• The Blood Pressure Lowering Treatment Trialists' Collaboration

  2001cited by this paper
• Impaired Coronary Tissue Plasminogen Activator Release Is Associated With Coronary Atherosclerosis and Cigarette Smoking: Direct Link Between Endothelial Dysfunction and Atherothrombosis

  2001cited by this paper
• Nimodipine Increases Fibrinolytic Activity in Patients With Aneurysmal Subarachnoid Hemorrhage

  2001influential reference
• A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with hunt-hess grade and outcome.

  2001cited by this paper
• Coagulative modifications in patients with systemic sclerosis treated with iloprost or nifedipine.

  2001influential reference
• Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during treatment of hypertension with cilnidipine.

  2000cited by this paper
• Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double‐blind parallel study versus amlodipine

  2000influential reference
• Association of blood pressure with fibrinolytic potential in the Framingham offspring population.

  2000cited by this paper
• Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients.

  2000influential reference
• Effects of cilnidipine on lipids, lipoproteins and fibrinolytic system in hypertensive patients.

  2000cited by this paper
• INFLUENCE OF BASELINE VALUES ON LIPIDS, LIPOPROTEINS AND FIBRINOLYTIC PARAMETERS DURING TREATMENT OF HYPERTENSION WITH CILNIDIPINE.

  2000cited by this paper
• Antifibrinolytic treatment in subarachnoid hemorrhage

  2000cited by this paper
• Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension.

  1999influential reference
• Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group.

  1999cited by this paper
• Relationship between endothelial function and fibrinolysis in early hypertension.

  1998cited by this paper
• Preeclampsia: Haemostatic Status and the Short‐Term Effects of Methyldopa and Isradipine Therapy

  1998influential reference
• Antihypertensive drug treatment and fibrinolytic function.

  1998cited by this paper
• Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage

  1998cited by this paper
• The action of calcium channel blockers on recombinant L‐type calcium channel α1‐subunits

  1998cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• THE EFFECTS OF CHRONIC SMOKING ON THE FIBRINOLYTIC POTENTIAL OF PLASMA AND PLATELETS

  1997cited by this paper
• Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.

  1997influential reference
• Pro-haemorrhagic effects of calcium antagonists: a comparison of isradipine and atenolol on ex vivo platelet function in hypertensive subjects

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• Effects of Nisoldipine on Cytosolic Calcium, Platelet Aggregation, and Coagulation/Fibrinolysis in Patients with Coronary Artery Disease

  1997influential reference
• Calcium-dependent Stabilization of Type I Plasminogen Activator Inhibitor within Plateletα-Granules (*)

  1996cited by this paper
• Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors

  1996influential reference
• The Yeast Transcription Terminator for RNA Polymerase I Is Designed to Prevent Polymerase Slippage*

  1996cited by this paper
• Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old

  1996cited by this paper
• Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

  1996cited by this paper
• Surgical bleeding: unexpected effect of a calcium antagonist

  1995cited by this paper
• Does Calcium Channel Blockade and (β‐Adrenergic Blockade Affect Platelet Function and Fibrinolysis to a Varying Degree?

  1995influential reference
• Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity. CaptISM Study Group. Captopril Insulin Sensitivity Multicenter Study Group.

  1994cited by this paper
• The role of endothelium in cardiovascular homeostasis and diseases.

  1993cited by this paper
• A comparison of heparin strategies after thrombolytic therapy.

  1993cited by this paper
• Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administration.

  1993cited by this paper
• Multicenter Evaluation of Commercially Available Methods for the Immunological Determination of Plasminogen Activator Inhibitor-1 (PAI-1)

  1993cited by this paper
• Decreased fibrinolytic activity and increased platelet function in hypertension. Possible influence of calcium antagonism.

  1991influential reference
• Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

  1991cited by this paper
• Does Antihypertensive Therapy Affect the Natural Protection Against Thrombosis?

  1991influential reference
• Differential effects of non-specific beta-blockade and calcium antagonism on blood-clotting mechanisms.

  1989influential reference
• Role of multiple cerebral microthrombosis in symptomatic cerebral vasospasm: with a case report.

  1983cited by this paper

• Enteral Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Real-World Application and Challenges.

  2025cites this paper
• Pathophysiological mechanisms underlying early brain injury and delayed cerebral ischemia in the aftermath of aneurysmal subarachnoid hemorrhage: a comprehensive analysis

  2025cites this paper
• Diagnosis and management of subarachnoid haemorrhage

  2024cites this paper
• Blood Pressure Changes in Association with Nimodipine Therapy in Patients with Spontaneous Subarachnoid Hemorrhage

  2023cites this paper
• Thrombocyte transfusion and rebleeding rate in patients using antiplatelet agents before aneurysmal subarachnoid hemorrhage.

  2023cites this paper
• Complications and Critical Care Management of Aneurysmal Subarachnoid Hemorrhage

  2021cites this paper
• Phase 1/2a Trial of ISPASM

  2021cites this paper
• Sustained Hippocampal Synaptic Pathophysiology Following Single and Repeated Closed-Head Concussive Impacts

  2021cites this paper
• An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage

  2021cites this paper
• Microthrombi Correlates With Infarction and Delayed Neurological Deficits After Subarachnoid Hemorrhage in Mice

  2020cites this paper
• Pleiotropic Antithrombotic Effects of Cardiovascular Drugs

  2020influential citation
• Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage.

  2019cites this paper
• Cerebrospinal Fluid Concentrations of Nimodipine Correlate With Long-term Outcome in Aneurysmal Subarachnoid Hemorrhage: Pilot Study.

  2019cites this paper
• 20 – The Medical Treatment of Stable Angina

  2018cites this paper
• Novel management strategies for medically-refractory vasospasm following aneurysmal subarachnoid hemorrhage.

  2018cites this paper
• Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage

  2018cites this paper
• Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case–Control Study

  2017cites this paper
• High Compliance with Scheduled Nimodipine Is Associated with Better Outcome in Aneurysmal Subarachnoid Hemorrhage Patients Cotreated with Heparin Infusion

  2017cites this paper
• Management of aneurysmal subarachnoid hemorrhage.

  2017cites this paper
• Déficit ischémique secondaire et hémorragie méningée, un nouveau paradigme

  2016cites this paper
• The critical care management of poor-grade subarachnoid haemorrhage

  2016cites this paper
• A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage

  2016cites this paper
• Randomized , Open-Label , Phase 1 / 2 a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage ( NEWTON [ Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage

  2016cites this paper
• Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])

  2016cites this paper
• Vasospasm: my first 25 years-what worked? what didn't? what next?

  2015cites this paper
• NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage

  2015cites this paper
• Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage

  2015cites this paper
• Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage.

  2015cites this paper
• Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions

  2015cites this paper
• Contribution of cerebral vasospasm to delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage.

  2014cites this paper
• A mild route for one pot synthesis of 5,6-unsubstituted 1,4-dihydropyridines catalyzed by sulphated mixed metal oxides

  2014cites this paper
• Angiographic vasospasm versus cerebral infarction as outcome measures after aneurysmal subarachnoid hemorrhage.

  2013cites this paper
• Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Hypertensive Patients and a Comparison of the Effects of Amlodipine and Ramipril on TAFI Levels

  2013cites this paper
• Current Management of Delayed Cerebral Ischemia: Update from Results of Recent Clinical Trials

  2013cites this paper
• SAHIT Investigators—on the Outcome of Some Subarachnoid Hemorrhage Clinical Trials

  2013cites this paper
• Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience

  2012cites this paper
• Nimodipine--oral or intravenous? No--subarachnoid.

  2012cites this paper
• Site-Specific, Sustained-Release Drug Delivery for Subarachnoid Hemorrhage

  2012cites this paper
• Intracranial drug delivery for subarachnoid hemorrhage.

  2012cites this paper
• Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm.

  2012cites this paper
• ASPECTS OF THE AMLODIPINE PLEIOTROPY IN BIOCHEMISTRY, PHARMACOLOGY AND CLINICS

  2012cites this paper
• Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.

  2012cites this paper
• Inhibition of MDR1 activity and induction of apoptosis by analogues of nifedipine and diltiazem: an in vitro analysis

  2011cites this paper
• Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis

  2011cites this paper
• Is There a Future for Neuroprotective Agents in Cardiac Surgery?

  2010cites this paper
• Alteration in voltage-dependent calcium channels in dog basilar artery after subarachnoid hemorrhage. Laboratory investigation.

  2010cites this paper
• Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.

  2010cites this paper
• Alteration in voltage-dependent calcium channels in dog basilar artery after subarachnoid hemorrhage

  2010cites this paper
• Thrombolysis for Acute Ischemic Stroke

  2009cites this paper
• Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage

  2009cites this paper
• Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage : the role of coagulation and fibrinolysis

  2009cites this paper
• Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia

  2009cites this paper
• Pharmacotherapy of cerebral ischemia

  2009cites this paper
• Nanoencapsulation of nimodipine in novel biocompatible poly(propylene-co-butylene succinate) aliphatic copolyesters for sustained release

  2009cites this paper
• Effects of amlodipine, diltiazem, and verapamil on the anticonvulsant action of topiramate against maximal electroshock-induced seizures in mice.

  2008cites this paper
• Microthrombosis after Aneurysmal Subarachnoid Hemorrhage: An Additional Explanation for Delayed Cerebral Ischemia

  2008cites this paper
• Becker Digital

  year unknowncites this paper